Photobiological modulation of hepatoma cell lines and hepatitis B subviral particles secretion in response to 650 nm low level laser treatment
CONCLUSIONS: The use of LLLT may be a promising therapy for HCC and HBV patients by reducing cell proliferation, HBVsvp production, and altering mitochondrial and nuclear structure involved in cellular death inducers. Further research is required to explore its clinical application.PMID:37870653 | DOI:10.1186/s43046-023-00190-3 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - October 23, 2023 Category: Cancer & Oncology Authors: Ghada M Al-Toukhy Reda A Suef Sarah Hassan Mohamed M S Farag Tarek A El-Tayeb Mohamed T M Mansour Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials
J Egypt Natl Canc Inst. 2023 Oct 2;35(1):32. doi: 10.1186/s43046-023-00192-1.ABSTRACTGastric cancer (GC) is the one of the most commonly solid cancer worldwide. Although under the aggressive treatment, the poor clinical outcomes of patients with GCs have not been improved. Current studies emphasized that targeting therapies or immune response-based therapeutic strategy may be a potential approach to improve the clinical outcomes. Moreover, accumulative evidence has reported the increasing expression of PD-L1 expression in GC cells and highlighted its role in the tumor progression. Currently, great development has been esta...
Source: J Egypt Natl Canc In... - October 1, 2023 Category: Cancer & Oncology Authors: Mengxiao Lu Yingjie Wu Yixin Zhang Yu Yu ShengJie Wang Xiaobao Su Source Type: research
